Justin Zamirowski's most recent trade in Better Therapeutics Inc was a trade of 1,677 Common Stock done at an average price of $0.5 . Disclosure was reported to the exchange on May 27, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Better Therapeutics Inc | Justin Zamirowski | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.50 per share. | 27 May 2022 | 1,677 | 36,913 | - | 0.5 | 839 | Common Stock |
| Better Therapeutics Inc | Justin Zamirowski | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2022 | 1,677 | 43,626 | - | - | Stock Option (Right to Buy) | |
| Better Therapeutics Inc | Justin Zamirowski | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2022 | 35,236 | 45,303 | - | - | Stock Option (Right to Buy) | |
| Better Therapeutics Inc | Justin Zamirowski | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.50 per share. | 16 May 2022 | 35,236 | 35,236 | - | 0.5 | 17,618 | Common Stock |
| Better Therapeutics Inc | Justin Zamirowski | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 86,800 | 86,800 | - | - | Stock Option (Right to Buy) |